Corcept Therapeutics Incorporated
IT ˙ BIT ˙ US2183521028
62,12 € 0,00 (0,00%)
2026-06-04
CENA AKCJI
SecurityIT:1CORT / Corcept Therapeutics Incorporated
InstitutionFifth Third Bancorp
Latest Disclosed Ownership37,242 shares
Latest Disclosed Value $ 1,501,242
Fifth Third Bancorp reports 881.60% increase in ownership of 1CORT / Corcept Therapeutics Incorporated

On May 1, 2026 - Fifth Third Bancorp filed a 13F-HR form disclosing ownership of 37,242 shares of Corcept Therapeutics Incorporated (IT:1CORT) valued at $1,260,269 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 3,794 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 881.60% during the quarter. The current value of the position is $2,313,473 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 37,242 33,448 881.60 1,501 1,037.12 0.0027
2026-02-02 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 3,794 3,046 407.22 132 112.90 0.0004
2025-11-07 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 748 42 5.95 62 21.57 0.0002
2025-07-15 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 706 -51 -6.74 52 -40.70 0.0002
2025-04-15 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 757 139 22.49 86 177.42 0.0003
2025-01-21 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 618 -9 -1.44 31 6.90 0.0001
2024-10-17 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 627 59 10.39 29 61.11 0.0001
2024-07-22 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 568 81 16.63 18 50.00 0.0001
2024-04-23 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 487 20 4.28 12 -20.00 0.0000
2024-01-19 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 467 0 0.00 15 25.00 0.0001
2023-10-31 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 467 0 0.00 13 20.00 0.0001
2023-07-26 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 467 0 0.00 10 0.00 0.0000
2023-04-24 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 467 147 45.94 10 66.67 0.0000
2023-01-25 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 320 -48 -13.04 6 -33.33 0.0000
2022-10-25 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 368 83 29.12 9 28.57 0.0000
2022-08-04 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 285 -48 -14.41 7 0.00 0.0000
2022-04-19 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 333 204 158.14 7 133.33 0.0000
2022-02-01 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 129 28 27.72 3 50.00 0.0000
2021-10-15 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 101 101 2 0.0000
2021-08-05 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 0 -253 -100.00 0 -100.00
2021-05-07 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 253 253 6 0.0000
2019-05-14 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -24,832 -100.00 0 -100.00
2019-02-14 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 24,832 -16,620 -40.09 332 -42.86 0.0024
2018-11-14 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 41,452 9,701 30.55 581 16.43 0.0037
2018-08-14 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 31,751 -1,460 -4.40 499 -8.61 0.0034
2018-05-15 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 33,211 33,211 546 0.0037
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.